Malík J, Murín J, Kasper J, Mikla F
I. interná klinika FN, Bratislava.
Vnitr Lek. 1997 Jun;43(6):366-8.
Based on clinical records (three years) the authors assessed the characteristics of patients with cardiogenic shock during myocardial infarction (48 of 270 patients with infarctions, i.e. 18%). The mortality of these patients was 77%. The incidence of cardiogenic shock evidently rose with age in both sexes and amounted to as much as 35% in the most advanced age groups. Other "risk factors" for the development of shock were arterial hypertension and diabetes. By dividing patients with myocardial infarction and cardiogenic shock into first infarctions (55%) and re-infarctions (45%) it was found that other risk factors for the development of cardiogenic shock are anterior localization of the infarction in first infarctions, and in re-infarctions it is in particular the number of previous infarctions (as they increase the size of the infarction focus). The authors point out that it is essential to pay increased attention to patients with acute infarction to prevent the development of cardiogenic shock (attempt thrombolytic treatment, treatment focused on prevention of ischaemia and arrhythmias). Apply also during its treatment thrombolysis or possibly PTCA.
基于临床记录(三年),作者评估了心肌梗死期间心源性休克患者的特征(270例梗死患者中有48例,即18%)。这些患者的死亡率为77%。心源性休克的发病率在男女两性中均随年龄显著上升,在最高年龄组中高达35%。休克发生的其他“危险因素”是动脉高血压和糖尿病。通过将心肌梗死合并心源性休克的患者分为首次梗死(55%)和再梗死(45%),发现首次梗死时心源性休克发生的其他危险因素是梗死的前壁定位,而再梗死时尤其是既往梗死的次数(因为它们会增加梗死灶的大小)。作者指出,必须更加关注急性梗死患者以预防心源性休克的发生(尝试溶栓治疗,专注于预防缺血和心律失常的治疗)。在其治疗期间也应进行溶栓或可能的经皮冠状动脉腔内血管成形术(PTCA)。